A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure

NCT00487799 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Facet no longer has ownership of ularitide.

Conditions

Heart Failure, Congestive

Interventions

DRUG: Ularitide

Sponsor

Facet Biotech